Oramed Pharmaceuticals annual operating expenses
2016
2017
2019
2022
2023
2024
2025
Oramed Pharmaceuticals Operating Expenses Growth & History (ORMP)
Oramed Pharmaceuticals's operating expenses was $15.1M for fiscal 2025.
View full Oramed Pharmaceuticals company overviewOramed Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $15.1M | $2.3M | +18.15% |
| 2024 | 2024-12-31 | $12.8M | −$4.3M | −25.30% |
| 2023 | 2023-12-31 | $17.1M | −$26.2M | −60.49% |
| 2022 | 2022-12-31 | $43.3M | — | — |
| 2019 | 2019-08-31 | $17.2M | — | — |
| 2017 | 2017-08-31 | $13.0M | $2.9M | +28.33% |
| 2016 | 2016-08-31 | $10.2M | — | — |
Oramed Pharmaceuticals quarterly operating expenses
Q2.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.19
Q2.19
Q3.19
Q4.19
Q1.21
Q1.21
Q2.21
Q3.21
Q3.22
Q1.22
Q1.22
Q2.22
Q3.22
Q3.22
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.8M | $277,000 | +11.13% |
| Q1 2026 | 2026-03-31 | $3.7M | −$854,000 | −18.92% |
| Q4 2025 | 2025-12-31 | $5.7M | — | — |
| Q3 2025 | 2025-09-30 | $2.4M | — | — |
| Q2 2025 | 2025-06-30 | $2.5M | — | — |
| Q1 2025 | 2025-03-31 | $4.5M | — | — |
| Q3 2022 · Sep 30 | 2022-09-30 | $11,000 | −$1,000 | −8.33% |
| Q3 2022 · Jun 30 | 2022-06-30 | $47,000 | −$27,000 | −36.49% |
| Q2 2022 | 2022-03-31 | $143,000 | $31,000 | +27.68% |
| Q1 2022 · Dec 31 | 2021-12-31 | $42,000 | $24,000 | +133.33% |
| Q1 2022 · Nov 30 | 2021-11-30 | $67,000 | −$7,000 | −9.46% |
| Q3 2022 · Sep 30 | 2021-09-30 | $12,000 | — | — |
| Q3 2021 · Jun 30 | 2021-06-30 | $74,000 | — | — |
| Q2 2021 · Mar 31 | 2021-03-31 | $112,000 | — | — |
| Q1 2021 · Dec 31 | 2020-12-31 | $18,000 | — | — |
| Q1 2021 · Nov 30 | 2020-11-30 | $74,000 | — | — |
| Q4 2019 | 2019-08-31 | $3.0M | — | — |
| Q3 2019 | 2019-05-31 | $4.8M | — | — |
| Q2 2019 | 2019-02-28 | $4.2M | — | — |
| Q1 2019 | 2018-11-30 | $5.3M | — | — |
| Q4 2017 | 2017-08-31 | $3.5M | — | — |
| Q3 2017 | 2017-05-31 | $2.8M | — | — |
| Q2 2017 | 2017-02-28 | $4.0M | $1.9M | +95.57% |
| Q1 2017 | 2016-11-30 | $2.8M | — | — |
| Q2 2016 | 2016-02-29 | $2.0M | — | — |
Oramed Pharmaceuticals operating expenses trends
Between the periods ended 2016-08-31 and 2025-12-31, Oramed Pharmaceuticals's operating expenses increased from $10.2M to $15.1M, a change of $4.9M. The latest reported quarter, Q2 2026, shows $2.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oramed Pharmaceuticals source filings ↗